Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027, Segmented By Nucleotide Sequenced (DNA v/s RNA), By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others), By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others), By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others), By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Global genome sequencing market is anticipated to grow with an impressive CAGR during the forecast years on the grounds of growing technological advancement in genetic sequencing and bioinformatics. Surge in the demand for the advanced pharmaceuticals and evolving infectious diseases further drive the growth of the global genome sequencing market in the upcoming five years. With consistent supply of financial funds from the government and higher research scope in the technology also supports the growth of the global genome sequencing market in the next five years. Moreover, growing instances of cancer and increasing applications of next generation sequencing in cancer research, the entry of new players and start-ups in the genomics industry further substantiates the growth of the global genome sequencing market in the forecast years.

Genome sequencing is a form of genetic engineering tool that can be defined as the method of identification and analysis of the genetic material found in any living organisms. Sequencing is basically identifying the DNA or RNA mapping sequences to diagnose the function of the translated protein and its effect on the organisms. The genome sequencing helps in identifying the threat or the properties of the evolution of the organisms. The process becomes highly apt for the healthcare processes where identification of the disease causing microorganisms can be carried out and design effective pharmaceutical and therapeutics along with precision medicine to treat these diseases.

Pharmaceutical Evolution Drives Market Growth

Increasing instances of infectious diseases and surge in the demands for the effective vaccinations and pharmaceutical products actively drive the growth of the global genome sequencing market in the upcoming five years. Application of genome sequencing for drug discovery and development increased in the recent years owing to the pandemic conditions caused due to viral infection of COVID-19. Sudden demand for the vaccination and treatment pharmaceuticals and therapeutics further aided to the growth of the global genome sequencing market in the future five years.

Detailed study on the genome (RNA) of the SARS-CoV-2 virus was conducted and multiple market players with the financial aids from the government discovered effective vaccine against the infection. High investments, reliability of the procedure, along with the threat of lost lives due to COVID-19 played major role in the recent developments in the genome sequencing thereby substantiating the growth of the global genome sequencing market in the forecast years. Government authorities like National Institutes for Health in the United States invested USD4435 Million in total human genome project that would be utilized for the further advancement of genome sequencing procedures.

Diagnostic Advances Through Genome Sequencing

Genome sequencing also allows detailed diagnosis of the organisms and their functions. Advancement in the biotechnological procedures and microbiology studies add to the growth of the global genome sequencing market in the upcoming five years. Procedures like next generation sequencing might be expensive but it provides simultaneous analysis of many genomic loci while revealing the exact sequence changes. For the diagnosis of cancer at early stage and to identify the complication of the chronic disease, the process allows clinicians to test many genes of a cancer simultaneously. The process has multiple advantages like ultra-high throughput, scalability, and speed, thus stimulating further demands and substantiating the market growth. The process is also actively utilized in next generation therapeutics development.

Higher prevalence of genetic mutations and environmental factors that play right into evolving the DNA or RNA of the organisms, require highly capable procedures of sequencing such that advancing and evolving genomes could be mapped. Identification of organisms is not only beneficial in case of diseases, but also to map the variants of species alive, thereby academic growth in the sequencing further facilitates the growth of the global genome sequencing market in the upcoming five years.


Click here to download the sample

Market Segmentation

The global genome sequencing market segmentation is based on nucleotide sequenced, technique, application, end user, regional distribution, and competitive landscape. Based on nucleotide sequenced, the market is differentiated between DNA and RNA. By technique, the market is further segmented into next generation sequencing, PCR, microarray technology, and others. Based on application, the market is bifurcated into diagnostics, drug discovery & development, precision medicine, and others. By end user, the market is fragmented into academic & research institutions, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Thermo Fisher Scientific, Inc., Ilumina, Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Danaher Corporation, are enlisted in a partial list of major market players of the global genome sequencing market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Nucleotide Sequenced

·         Technique

·         Application

·         End User

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, Australia, South Korea, Germany, France, United Kingdom, Italy, Spain, Brazil, Argentina, Colombia, South Africa, UAE, Saudi Arabia.

Key companies profiled

Thermo Fisher Scientific, Inc., Ilumina, Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Danaher Corporation

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global genome sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genome Sequencing Market, By Nucleotide Sequenced:
    • DNA
    • RNA
  • Genome Sequencing Market, By Technique:
    • Next Generation Sequencing
    • Polymerase Chain Reaction (PCR)
    • Microarray Technology
    • Others
  • Genome Sequencing Market, By Application:
    • Diagnostics
    • Drug Discovery & Development
    • Precision Medicine
    • Others
  • Genome Sequencing Market, By End User:
    • Academic & Research Institutions
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinics
    • Others
  • Genome Sequencing Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genome sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Global Genome Sequencing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Genome Sequencing Market

5.    Voice of Customer

5.1.  Factors Contributing to Demand for Genome Sequencing

5.2.  Source of Information

5.3.  Commonly Sequenced Nucleotides

5.4.  Preference, By Technique

5.5.  Demand, By Application

5.6.  Brand Awareness

6.    Global Genome Sequencing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Nucleotide Sequenced (DNA v/s RNA)

6.2.2.     By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others)

6.2.3.     By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others)

6.2.4.     By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)

6.2.5.     By Company (2021)

6.2.6.     By Region

6.3.  Product Market Map

7.    North America Genome Sequencing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Nucleotide Sequenced

7.2.2.     By Technique

7.2.3.     By Application

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Genome Sequencing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Nucleotide Sequenced

7.3.1.2.2.             By Technique

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Mexico Genome Sequencing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Nucleotide Sequenced

7.3.2.2.2.             By Technique

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Canada Genome Sequencing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Nucleotide Sequenced

7.3.3.2.2.             By Technique

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

8.    Europe Genome Sequencing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Nucleotide Sequenced

8.2.2.     By Technique

8.2.3.     By Application

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Genome Sequencing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Nucleotide Sequenced

8.3.1.2.2.             By Technique

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     Germany Genome Sequencing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Nucleotide Sequenced

8.3.2.2.2.             By Technique

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Genome Sequencing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Nucleotide Sequenced

8.3.3.2.2.             By Technique

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     Italy Genome Sequencing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Nucleotide Sequenced

8.3.4.2.2.             By Technique

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Genome Sequencing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Nucleotide Sequenced

8.3.5.2.2.             By Technique

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

9.    Asia-Pacific Genome Sequencing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Nucleotide Sequenced

9.2.2.     By Technique

9.2.3.     By Application

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Genome Sequencing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Nucleotide Sequenced

9.3.1.2.2.             By Technique

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     India Genome Sequencing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Nucleotide Sequenced

9.3.2.2.2.             By Technique

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     South Korea Genome Sequencing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Nucleotide Sequenced

9.3.3.2.2.             By Technique

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

9.3.4.     Japan Genome Sequencing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Nucleotide Sequenced

9.3.4.2.2.             By Technique

9.3.4.2.3.             By Application

9.3.4.2.4.             By End User

9.3.5.     Australia Genome Sequencing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Nucleotide Sequenced

9.3.5.2.2.             By Technique

9.3.5.2.3.             By Application

9.3.5.2.4.             By End User

10.  South America Genome Sequencing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Nucleotide Sequenced

10.2.2.  By Technique

10.2.3.  By Application

10.2.4.  By End User

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Genome Sequencing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Nucleotide Sequenced

10.3.1.2.2.           By Technique

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Argentina Genome Sequencing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Nucleotide Sequenced

10.3.2.2.2.           By Technique

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Colombia Genome Sequencing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Nucleotide Sequenced

10.3.3.2.2.           By Technique

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Middle East and Africa Genome Sequencing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Nucleotide Sequenced

11.2.2.  By Technique

11.2.3.  By Application

11.2.4.  By End User

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Genome Sequencing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Nucleotide Sequenced

11.3.1.2.2.           By Technique

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  Saudi Arabia Genome Sequencing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Nucleotide Sequenced

11.3.2.2.2.           By Technique

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  UAE Genome Sequencing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Nucleotide Sequenced

11.3.3.2.2.           By Technique

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Company Details

14.1.2.  Financials (As reported)

14.1.3.  Key Market Focus and Geographical Presence

14.1.4.  Pricing of Target Products

14.1.5.  Market positioning

14.2.              Thermo Fisher Scientific, Inc.

14.3.              Ilumina, Inc.

14.4.              QIAGEN N.V.

14.5.              Eurofins Scientific SE

14.6.              Agilent Technologies, Inc.

14.7.              Oxford Nanopore Technologies Limited

14.8.              F. Hoffmann-La Roche AG

14.9.              Bio-Rad Laboratories, Inc.

14.10.            Abbott Laboratories, Inc.

14.11.            Danaher Corporation

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Global genome sequencing market may grow with impressive CAGR during the forecast period, 2023-2027, on account of higher demands of expanding biotechnology sector and growing investment in the biotech-healthcare sector.

down-arrow

Based on application, the market is bifurcated into diagnostics, drug discovery & development, precision medicine, and others. Drug discovery & development applications are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to expanding pharmaceutical industry and growing investments in the innovative drug development.

down-arrow

Thermo Fisher Scientific, Inc., Ilumina, Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Danaher Corporation, among others are some of the leading companies dedicated toward providing related products and services of genome sequencing and support the future growth of the global genome sequencing market in the upcoming five years.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Genome Sequencing Market Is Led by Advancing Biotechnology

Jun, 2022

Growing investments in the genetic engineering tools drive the growth of the Global Genome Sequencing Market.

Why Choose Us